What about (MG)US? Towards tailored testing in monoclonal gammopathies
- PMID: 36453107
- PMCID: PMC10230406
- DOI: 10.3324/haematol.2022.282271
What about (MG)US? Towards tailored testing in monoclonal gammopathies
Figures
Comment on
-
Monoclonal gammopathy of increasing significance: time to screen?Haematologica. 2023 Jun 1;108(6):1476-1486. doi: 10.3324/haematol.2022.281802. Haematologica. 2023. PMID: 36373250 Free PMC article. Review.
Similar articles
-
When a Monoclonal Gammopathy Is Not Multiple Myeloma.Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-10. doi: 10.1200/EDBK_349643. Am Soc Clin Oncol Educ Book. 2022. PMID: 35394823 Review.
-
[Skin disorders associated with monoclonal gammopathies].Ned Tijdschr Geneeskd. 2014;158:A6717. Ned Tijdschr Geneeskd. 2014. PMID: 24780569 Review. Dutch.
-
[Monoclonal gammopathies].Ugeskr Laeger. 2021 Oct 18;183(42):V03210258. Ugeskr Laeger. 2021. PMID: 34709161 Review. Danish.
-
Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.Hematol Oncol Clin North Am. 2014 Oct;28(5):775-90. doi: 10.1016/j.hoc.2014.06.005. Epub 2014 Jul 22. Hematol Oncol Clin North Am. 2014. PMID: 25212882 Review.
-
Ocular copper deposition associated with monoclonal gammopathy of undetermined significance: case report.Arq Bras Oftalmol. 2005 Jul-Aug;68(4):539-41. doi: 10.1590/s0004-27492005000400021. Epub 2005 Nov 22. Arq Bras Oftalmol. 2005. PMID: 16322842
References
-
- Dutta AK, Alberge JB, Sklavanitis-Pistofidis R, Lightbody ED, Getz G, Ghobrial IM. Single-cell profiling of tumour evolution in multiple myeloma - opportunities for precision medicine. Nat Rev Clin Oncol. 2022;19(4):223-236. - PubMed
-
- Kourelis TV, Dasari S, Theis JD, et al. . Clarifying immunoglobulin gene usage in systemic and localized immunoglobulin light-chain amyloidosis by mass spectrometry. Blood. 2017;129(3):299-306. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources